dr. figlin on promise of immunotherapy plus tki combinations in rcc
Published 5 years ago • 78 plays • Length 1:32Download video MP4
Download video MP3
Similar videos
-
1:15
dr. figlin on toxicity profile of immunotherapy/vegf tki combinations in rcc
-
1:54
dr. figlin on tki therapy options in renal cell carcinoma
-
1:18
dr. figlin on considerations for combining tkis and immunotherapy in rcc
-
2:16
dr. amin on toxicities with immunotherapy/tki combinations in rcc
-
0:53
dr. figlin on advances in immunotherapy for kidney cancer
-
1:44
dr. figlin discusses sequencing mtor inhibitors and tkis in rcc
-
1:17
dr. figlin on the evolving treatment landscape of renal cell carcinoma
-
8:07
vegf tki immunotherapy combinations for mrcc
-
1:09
robert figlin, md, on appropriate patient types to receive a tki in the treatment of 1st line rcc
-
1:25
dr. figlin on ongoing adapt trial for mrcc
-
1:25
dr. figlin discusses the future of kidney cancer treatment
-
1:57
dr. robert figlin on the increasingly complicated treatment paradigm for renal cell carcinoma
-
1:04
dr. figlin on intermediate prognosis patients with mrcc
-
18:11
immunotherapy robert a. figlin, m.d.
-
1:53
dr. figlin on next steps for research in mrcc
-
1:44
immunotherapy: how t cells fight cancer
-
2:00
the promise of cancer immunotherapy
-
3:47
other clinical trials in renal cell carcinoma
-
1:25
robert figlin, md discusses how lenvatanib will fit into the advanced rcc treatment algorithm